RHP Mrv0541 02231217352D 15 16 0 0 0 0 999 V2000 -2.0428 2.5600 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.7878 1.7754 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.5329 0.9907 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.7259 0.8192 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -0.4710 0.0346 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 -0.9559 -0.6328 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.4710 -1.3003 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.3136 -1.0453 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.3136 -0.2203 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.0281 0.1922 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.0281 -1.4578 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.7426 -1.0453 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.7426 -0.2203 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.4570 0.1922 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -1.0477 0.1259 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0 1 2 3 0 0 0 0 2 3 1 0 0 0 0 3 4 1 0 0 0 0 5 4 1 1 0 0 0 5 6 1 0 0 0 0 5 9 1 0 0 0 0 5 15 1 6 0 0 0 6 7 1 0 0 0 0 7 8 1 0 0 0 0 8 9 1 0 0 0 0 8 11 2 0 0 0 0 9 10 2 0 0 0 0 10 13 1 0 0 0 0 11 12 1 0 0 0 0 12 13 2 0 0 0 0 13 14 1 0 0 0 0 M END > DB04307 > drugbank > [H][C@]1(CCC2=CC=C(O)C=C12)NCC#C > InChI=1S/C12H13NO/c1-2-7-13-12-6-4-9-3-5-10(14)8-11(9)12/h1,3,5,8,12-14H,4,6-7H2/t12-/m1/s1 > InChIKey=NRSDGDXUWMMUEV-GFCCVEGCSA-N > 2 > 21.111973161529733 > 1 > 2 > 187.099714043 > 0 > C12H13NO > 1 > (3R)-3-[(prop-2-yn-1-yl)amino]-2,3-dihydro-1H-inden-5-ol > 1.32 > 1.8533161324408474 > -3.44 > 187.2377 > 0 > 2 > 1 > 9.73075356831204 > 8.20543631307957 > 32.26 > 56.44790000000001 > 2 > 1 > 6.79e-02 g/l > (3R)-3-(prop-2-yn-1-ylamino)-2,3-dihydro-1H-inden-5-ol > 1 > DB04307 > experimental > 5-Hydroxy-N-Propargyl-1(R)-Aminoindan $$$$